Quantcast

Latest BC Cancer Agency Stories

2014-06-09 08:29:41

Demonstrates Technology Suitable & Scalable for Multiple Brands of Cyclotrons ST. LOUIS, MO, June 9, 2014 /CNW/ - Today at the Society of Nuclear Medicine and Molecular Imaging's annual conference, a Canadian team with members from TRIUMF, the BC Cancer Agency, the Centre for Probe Development & Commercialization, and Lawson Health Research Institute announced that they have dramatically advanced technology for addressing the medical-isotope crisis. The key medical isotope,...

2011-12-22 10:12:58

An important breakthrough in cancer research Scientists at the BC Cancer Agency, Vancouver Coastal Health Research Institute, and the University of British Columbia are excited over a discovery made while studying rare tumor types. Dr. David Huntsman, genetic pathologist and director of the Ovarian Cancer Program of BC at the BC Cancer Agency and Vancouver Coastal Health Research Institute and Dr. Gregg Morin, a lead scientist from the Michael Smith Genome Sciences Centre at the BC...

2011-07-07 00:00:29

The results of a pilot study on lung cancer detection will be published in the prestigious Journal of Thoracic Oncology in July Vancouver, Canada (PRWEB) July 06, 2011 Verisante Technology, Inc. (TSX-V: VRS; OTCQX: VRSEF) (the "Company" or "Verisante") is pleased to announce that the results of a pilot study on lung cancer detection will be published in the prestigious Journal of Thoracic Oncology in July. The results of the pilot study indicate that the Company's system technology could...

2011-06-15 00:00:28

Verisante purchases endoscopy systems for early lung cancer detection to compliment Verisante Core Vancouver, Canada (PRWEB) June 13, 2011 Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the "Company" or "Verisante") announced today that the Company has entered into an Asset Purchase Agreement with Perceptronix Medical Inc. ("PMI"). Under the terms of the Agreement, Verisante has purchased all rights to the ClearVuâ“ž¢ and ClearVu...

2011-04-01 07:30:00

BALTIMORE, Md., April 1, 2011 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC: CSBR) ("Champions" or "the Company") announced today that it has exercised an option to license Irinophore C(TM), a liposomal formulation of Irinotecan, from the BC Cancer Agency ("BCCA") in British Columbia, Canada. This action was the result of the positive results obtained from a Tumorgraft(TM) study done on Irinophore C(TM) utilizing Champions' proprietary technology platform. Irinophore C(TM) is a...

2010-09-08 16:04:00

VANCOUVER, Sept. 8 /PRNewswire/ - Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun an important campaign that will reduce deaths from ovarian cancer. They are asking all BC gynecologists to change surgical practice to fully remove the fallopian tube when performing hysterectomy or tubal ligation. Current practice leaves the fallopian tube in place for many types of hysterectomy and tubal ligation. This is...

2009-06-11 08:13:37

Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer. This means that out of the three billion nucleotide pairs that make up the genetic code of the tumour, one "“ the same one in every tumour sample "“ is incorrect. The...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related